These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36839301)

  • 1. ATP and NAD
    Mischley LK; Shankland E; Liu SZ; Bhayana S; Fox DJ; Marcinek DJ
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease.
    Kestenbaum B; Gamboa J; Liu S; Ali AS; Shankland E; Jue T; Giulivi C; Smith LR; Himmelfarb J; de Boer IH; Conley K; Roshanravan B
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson's Patients, Using In Vivo
    Zhu XH; Lee BY; Tuite P; Coles L; Sathe AG; Chen C; Cloyd J; Low WC; Steer CJ; Chen W
    Metabolites; 2021 Mar; 11(3):. PubMed ID: 33804401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease.
    Taylor DJ; Krige D; Barnes PR; Kemp GJ; Carroll MT; Mann VM; Cooper JM; Marsden CD; Schapira AH
    J Neurol Sci; 1994 Aug; 125(1):77-81. PubMed ID: 7964892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials.
    Ren J; Dewey RB; Rynders A; Evan J; Evan J; Ligozio S; Ho KS; Sguigna PV; Glanzman R; Hotchkin MT; Dewey RB; Greenberg BM
    J Nanobiotechnology; 2023 Dec; 21(1):478. PubMed ID: 38087362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Sassani M; Alix JJ; McDermott CJ; Baster K; Hoggard N; Wild JM; Mortiboys HJ; Shaw PJ; Wilkinson ID; Jenkins TM
    Brain; 2020 Dec; 143(12):3603-3618. PubMed ID: 33439988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.
    Kelly NA; Ford MP; Standaert DG; Watts RL; Bickel CS; Moellering DR; Tuggle SC; Williams JY; Lieb L; Windham ST; Bamman MM
    J Appl Physiol (1985); 2014 Mar; 116(5):582-92. PubMed ID: 24408997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
    Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
    J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study.
    Sathe AG; Tuite P; Chen C; Ma Y; Chen W; Cloyd J; Low WC; Steer CJ; Lee BY; Zhu XH; Coles LD
    J Clin Pharmacol; 2020 Jun; 60(6):744-750. PubMed ID: 32052462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of muscle mitochondrial respiratory chain phenotyping across the cognitive spectrum in Parkinson's disease.
    Yarnall AJ; Granic A; Waite S; Hollingsworth KG; Warren C; Vincent AE; Turnbull DM; Taylor RW; Dodds RM; Sayer AA
    Exp Gerontol; 2020 Sep; 138():110997. PubMed ID: 32554091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface EMG activity during REM sleep in Parkinson's disease correlates with disease severity.
    Chahine LM; Kauta SR; Daley JT; Cantor CR; Dahodwala N
    Parkinsonism Relat Disord; 2014 Jul; 20(7):766-71. PubMed ID: 24787758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].
    Nodel MR; Ukraintseva YV; Yakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):15-20. PubMed ID: 29053115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.
    Smith AM; Depp C; Ryan BJ; Johnston GI; Alegre-Abarrategui J; Evetts S; Rolinski M; Baig F; Ruffmann C; Simon AK; Hu MTM; Wade-Martins R
    Mov Disord; 2018 Oct; 33(10):1580-1590. PubMed ID: 30294923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.
    Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
    Parkinsonism Relat Disord; 2014 May; 20(5):545-8. PubMed ID: 24593902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy.
    Blin O; Desnuelle C; Rascol O; Borg M; Peyro Saint Paul H; Azulay JP; Billé F; Figarella D; Coulom F; Pellissier JF
    J Neurol Sci; 1994 Aug; 125(1):95-101. PubMed ID: 7964895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial.
    Roshanravan B; Liu SZ; Ali AS; Shankland EG; Goss C; Amory JK; Robertson HT; Marcinek DJ; Conley KE
    PLoS One; 2021; 16(7):e0253849. PubMed ID: 34264994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder.
    Ansari M; Rahmani F; Dolatshahi M; Pooyan A; Aarabi MH
    Sleep Breath; 2017 Mar; 21(1):155-161. PubMed ID: 27853964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of REM sleep behavior disorders in patients with Parkinson's disease.
    Janković M; Svetel M; Kostić V
    Vojnosanit Pregl; 2015 May; 72(5):442-6. PubMed ID: 26165053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.
    Suzuki K; Miyamoto T; Miyamoto M; Watanabe Y; Suzuki S; Tatsumoto M; Iwanami M; Sada T; Kadowaki T; Numao A; Hashimoto K; Sakuta H; Hirata K
    BMC Neurol; 2013 Feb; 13():18. PubMed ID: 23394437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.